Skip to main content
Roberta Florido
( out of 39 reviews )

Roberta Florido, MD, MHS

Languages spoken: Portuguese, Spanish, English, French

Clinical Locations

Primary Location

University of Utah Hospital

Heart Failure Clinic
50 N Medical Dr
Salt Lake City , UT 84132

Cardiovascular Center

Cardiovascular Center
50 N Medical Dr
Salt Lake City , UT 84132

Dr. Florido completed medical training at the Universidade Federal do Rio de Janeiro in Brazil, graduating cum laude. She received training in Internal Medicine at Boston University, where she was also selected to serve as a chief medical resident. She subsequently completed fellowships in cardiology and advanced heart failure at Johns Hopkins and a Master’s in Health Sciences at the Johns Hopkins Bloomberg School of Public Health, receiving numerous awards. She joined the faculty at Johns Hopkins in August of 2018, where she created and directed the cardio oncology program. In 2023 Dr. Florido joined the Advanced Heart Failure and Transplant group at the University of Utah as an Associated Professor and the Director of Cardio-Oncology. In 2025 she was selected as program director of the Advanced Heart Failure and Transplant Cardiology Fellowship.

Dr. Florido has led several studies assessing the impact of lifestyle related factors such as physical activity and adiposity on reducing the risk of heart failure, both in the general population and in particular within high-risk subgroups. Additionally, she has examined the role of novel biomarkers of subclinical myocardial injury and fibrosis in the associations of physical activity and adiposity with incident heart failure. Within the field of cardio-oncology, she has examined the distribution of biomarkers of subclinical myocardial injury in cancer survivors as indicators of long-term heart failure risk. She has also studied the associations of cancer survivorship with cardiovascular disease events.

Dr. Florido has clinical expertise in advanced heart failure, mechanical circulatory support, heart transplantation, and cardio-oncology. Her academic interests are in heart failure prevention and cardio oncology.

Board Certification

American Board of Internal Medicine (Sub: Cardiovascular Disease)
American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
Educational Commission for Foreign Medical Graduates

Patient Rating

4.8 /5
( out of 39 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

2026-01-11
UNIVERSITY HOSPITAL

Dr Florida was great! Very knowledgeable, a good listener, and answered all of our questions. She explained options and possible timelines.

2025-06-28
UNIVERSITY HOSPITAL

She showed concern, was very thorough & explained things to our understanding.

2025-06-19
UNIVERSITY HOSPITAL

She is a wonderful, smart and caring professional.

2025-05-05
UNIVERSITY HOSPITAL

Dr Florida comes with full confidence in what is needed by me and presents a plan for the future. Helping me understand why she thinks it best. Very respectful and attentive. She uplifts me when IÕm down and has such a great personality. IÕm so glad she took time for me. She makes me fill important and help one with my struggles. I thank her from the bottom of my heart. BBB

2025-03-31
UNIVERSITY HOSPITAL

She did a great job.

2025-03-22
UNIVERSITY HOSPITAL

She listens, I mean really listens to me.

2025-03-21
UNIVERSITY HOSPITAL

Dr. Florido ranks as one of the best Heart Transplant Cardiologists that I have ever seen. She has the Technical skills as well as the Communication skills that are so important to me as a heart transplant patient. I saw Dr. Florido for my 5 year heart transplant appointment. When you speak with Dr. Florido, she makes you feel like you are the most important person in the world during your appointment. All of her energy is focused on you. I feel so lucky that she is on my team and is looking out for me. Thank you from the bottom of my heart.

2025-03-14
UNIVERSITY HOSPITAL

Awesome Doctor

2025-02-06
UNIVERSITY HOSPITAL

Dr. Florido is an excellent physician.

Dr. Florido completed medical training at the Universidade Federal do Rio de Janeiro in Brazil, graduating cum laude. She received training in Internal Medicine at Boston University, where she was also selected to serve as a chief medical resident. She subsequently completed fellowships in cardiology and advanced heart failure at Johns Hopkins and a Master’s in Health Sciences at the Johns Hopkins Bloomberg School of Public Health, receiving numerous awards. She joined the faculty at Johns Hopkins in August of 2018, where she created and directed the cardio oncology program. In 2023 Dr. Florido joined the Advanced Heart Failure and Transplant group at the University of Utah as an Associated Professor and the Director of Cardio-Oncology. In 2025 she was selected as program director of the Advanced Heart Failure and Transplant Cardiology Fellowship.

Dr. Florido has led several studies assessing the impact of lifestyle related factors such as physical activity and adiposity on reducing the risk of heart failure, both in the general population and in particular within high-risk subgroups. Additionally, she has examined the role of novel biomarkers of subclinical myocardial injury and fibrosis in the associations of physical activity and adiposity with incident heart failure. Within the field of cardio-oncology, she has examined the distribution of biomarkers of subclinical myocardial injury in cancer survivors as indicators of long-term heart failure risk. She has also studied the associations of cancer survivorship with cardiovascular disease events.

Dr. Florido has clinical expertise in advanced heart failure, mechanical circulatory support, heart transplantation, and cardio-oncology. Her academic interests are in heart failure prevention and cardio oncology.

Board Certification and Academic Information

Academic Departments Internal Medicine -Associate Professor (Clinical)
Academic Divisions Cardiovascular Medicine
Board Certification
American Board of Internal Medicine (Sub: Cardiovascular Disease)
American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
Educational Commission for Foreign Medical Graduates

Education history

Professional Medical Medicine - Universidade Federal do Rio de Janeiro M.D.
Research Fellow Aging - Mayo Clinic Postdoctoral Research Fellow
Residency Internal Medicine - Boston University School of Medicine Resident
Residency Internal Medicine - Boston University School of Medicine Chief Resident
Fellowship Cardiovascular Diseases - John Hopkins University School of Medicine Fellow
Graduate Training Cardiovascular Epidemiology - Johns Hopkins Bloomberg School of Public Health M.H.S.
Fellowship Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support - John Hopkins University School of Medicine Fellow

Selected Publications

Journal Article

  1. Steiling K, van den Berge M, Hijazi K, Florido R, Campbell J, Liu G, Xiao J, Zhang X, Duclos G, Drizik E, Si H, Perdomo C, Dumont C, Coxson HO, Alekseyev YO, Sin D, Pare P, Hogg JC, McWilliams A, Hiemstra PS, Sterk PJ, Timens W, Chang JT, Sebastiani P, O'Connor GT, Bild AH, Postma DS, Lam S, Spira A, Lenburg ME (2013). A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med, 187(9), 933-42.
  2. Florido R, Zhao D, Ndumele CE, Lutsey PL, McEvoy JW, Windham BG, Pankow JS, Guallar E, Michos ED (2016). Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study. J Am Heart Assoc, 5(9).
  3. Chin K, Zhao D, Tibuakuu M, Martin SS, Ndumele CE, Florido R, Windham BG, Guallar E, Lutsey PL, Michos ED (2017). Physical Activity, Vitamin D, and Incident Atherosclerotic Cardiovascular Disease in Whites and Blacks: The ARIC Study. J Clin Endocrinol Metab, 102(4), 1227-1236.
  4. Florido R, Ndumele CE, Kwak L, Pang Y, Matsushita K, Schrack JA, Lazo M, Nambi V, Blumenthal RS, Folsom AR, Coresh J, Ballantyne CM, Selvin E (2017). Physical Activity, Obesity, and Subclinical Myocardial Damage. JACC Heart Fail, 5(5), 377-384.
  5. Fretz A, McEvoy JW, Rebholz CM, Ndumele CE, Florido R, Hoogeveen RC, Ballantyne CM, Selvin E (2018). Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study). Am J Cardiol, 121(4), 430-436.
  6. Florido R, Kwak L, Lazo M, Nambi V, Ahmed HM, Hegde SM, Gerstenblith G, Blumenthal RS, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE (2018). Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study. Circulation, 137(20), 2142-2151.
  7. Porter AK, Schilsky S, Evenson KR, Florido R, Palta P, Holliday KM, Folsom AR (2019). The Association of Sport and Exercise Activities With Cardiovascular Disease Risk: The Atherosclerosis Risk in Communities (ARIC) Study. J Phys Act Health, 16(9), 698-705.
  8. Florido R, Zhao DI, Ndumele CE, Bluemke DA, Heckbert SR, Allison MA, Ambale-Venkatesh B, Liu CY, Lima J, Michos ED (2019). Change in Physical Activity and Cardiac Structure over 10 Years: The Multi-Ethnic Study of Atherosclerosis. Med Sci Sports Exerc, 51(10), 2033-2040.
  9. Scheel PJ 3rd, Florido R, Hsu S, Murray B, Tichnell C, James CA, Agafonova J, Tandri H, Judge DP, Russell SD, Tedford RJ, Calkins H, Gilotra NA (2020). Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. J Am Heart Assoc, 9(3), e013695.
  10. Florido R, Kwak L, Lazo M, Michos ED, Nambi V, Blumenthal RS, Gerstenblith G, Palta P, Russell SD, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE (2020). Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study. J Am Heart Assoc, 9(10), e014885.
  11. Echouffo-Tcheugui JB, Zhang S, Florido R, Hamo C, Pankow JS, Michos ED, Goldberg RB, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E, Ndumele CE (2021). Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study. JACC Heart Fail, 9(8), 594-603.
  12. Goldberg RL, Freed KE, Klemans N, Fioretti R, Choi CW, Kilic A, Adamo L, Florido R, Sharma K, Gilotra NA, Hsu S (2021). Angiotensin Receptor-Neprilysin Inhibition Improves Blood Pressure and Heart Failure Control in Left Ventricular Assist Device Patients. ASAIO J, 67(12), e207-e210.
  13. Giuliano K, Scheel P 3rd, Etchill E, Fraser CD 3rd, Suarez-Pierre A, Hsu S, Wittstein IS, Kasper EK, Florido R, Tandri H, Calkins H, Choi CW, Sharma K, Kilic A, Gilotra NA (2022). Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis. ESC Heart Fail, 9(2), 988-997.
  14. Hamo CE, Kwak L, Wang D, Florido R, Echouffo-Tcheugui JB, Blumenthal RS, Loehr L, Matsushita K, Nambi V, Ballantyne CM, Selvin E, Folsom AR, Heiss G, Coresh J, Ndumele CE (2022). Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study. J Am Heart Assoc, 11(4), e021583.
  15. Florido R, Kwak L, Echouffo-Tcheugui JB, Zhang S, Michos ED, Nambi V, Goldberg RB, Hoogeveen RC, Lazo M, Gerstenblith G, Post WS, Blumenthal RS, Coresh J, Folsom AR, Selvin E, Ballantyne C, Ndumele CE (2022). Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc, 11(9), e023238.
  16. Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, Blumenthal RS, Matsushita K, Mok Y, Felix AS, Coresh J, Joshu CE, Platz EA, Selvin E (2022). Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol, 80(1), 22-32.
  17. Florido R, Lee AK, McEvoy JW, Hoogeveen RC, Koton S, Vitolins MZ, Shenoy C, Russell SD, Blumenthal RS, Ndumele CE, Ballantyne CM, Joshu CE, Platz EA, Selvin E (2019). Cancer Survivorship and Subclinical Myocardial Damage. Am J Epidemiol, 188(12), 2188-2195.
  18. Polter EJ, Blaes A, Wolfson J, Lutsey PL, Florido R, Joshu CE, Guha A, Platz EA, Prizment A (2023). Performance of the pooled cohort equations in cancer survivors: the Atherosclerosis Risk in Communities study.(Epub ahead of print). J Cancer Surviv.
  19. Echouffo-Tcheugui JB, Ndumele CE, Zhang S, Florido R, Matsushita K, Coresh J, Skali H, Shah AM, Selvin E (2022). Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol, 79(23), 2285-2293.
  20. Hamo CE, Echouffo-Tcheugui JB, Zhang S, Florido R, Pankow JS, Michos ED, Goldberg R, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne C, Selvin E, Coresh J, Ndumele CE (2022). Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC). Clin Chem, 68(10), 1272-1280.
  21. Hawwash NK, Sperrin M, Martin GP, Joshu CE, Florido R, Platz EA, Renehan AG (2023). Overweight-years and cancer risk: A prospective study of the association and comparison of predictive performance with body mass index (Atherosclerosis Risk in Communities Study).(Epub ahead of print). Int J Cancer.
  22. Pavlovic N, Ndumele CE, Abshire Saylor M, Szanton SL, Lee CS, Shah AM, Chang PP, Florido R, Matsushita K, Himmelfarb C, Leoutsakos JM (2024). Identification of Fatigue Subtypes and Their Correlates in Prevalent Heart Failure: A Secondary Analysis of the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Qual Outcomes, 17(2), e010115.
  23. Echouffo-Tcheugui JB, Zhang S, Florido R, Pankow JS, Michos ED, Goldberg RB, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E, Ndumele CE (2024). Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc, 13(6), e031607.
  24. Power JR, Dolladille C, Ozbay B, Procureur AM, Ederhy S, Palaskas NL, Lehmann LH, Cautela J, Courand PY, Hayek SS, Zhu H, Zaha VG, Cheng RK, Alexandre J, Roubille F, Baldassarre LA, Chen YC, Baik AH, Laufer-Perl M, Tamura Y, Asnani A, Francis S, Gaughan EM, Rainer PP, Bailly G, Flint D, Arangalage D, Cariou E, Florido R, Narezkina A, Liu Y, Sandhu S, Leong D, Issa N, Piriou N, Heinzerling L, Peretto G, Crusz SM, Akhter N, Levenson JE, Turker I, Eslami A, Fenioux C, Moliner P, Obeid M, Chan WT, Ewer SM, Kassaian SE, International ICI-Myocarditis Registry, Johnson DB, Nohria A, Zadok OIB, Moslehi JJ, Salem JE (2024). Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity.
  25. Ozkan B, Zhang S, Echouffo-Tcheugui JB, Florido R, Nambi V, Michos ED, Abushamat LA, Matsushita K, Gerstenblith G, Blumenthal RS, Hoogeveen R, Ballantyne CM, Coresh J, Selvin E, Ndumele CE (2025). Adipokines and Transitions in Metabolic Health Over Time: The Atherosclerosis Risk In Communities (ARIC) Study.(Epub ahead of print). J Clin Endocrinol Metab.
  26. Nohara S, Mok Y, Van't Hof JR, Salameh M, Joshu CE, Platz EA, Florido R, Matsushita K (2025). Subsequent risk of cancer among adults with peripheral artery disease in the community: The atherosclerosis risk in communities (ARIC) study. Int J Cardiol, 418, 132577.
  27. Hawwash N, Sperrin M, Martin GP, Joshu CE, Florido R, Platz EA, Renehan AG (2024). Waist circumference-years and cancer risk: a prospective study of the association and comparison of predictive performance with waist circumference and body mass index. Br J Cancer, 131(10), 1623-1634.
  28. Malik S, Guha A, Wang X, Weintraub NL, Harris R, Datta B, Moore J, Nain P, Patel SA, Coughlin S, Polter E, Prizment A, Blaes A, Florido R, Kutty S, Alonso A, Joshu CE, Platz EA (2024). Association Between Obesity and Risk of Total and Obesity-Related Cancer in People With Incident Cardiovascular Disease. J Am Heart Assoc, 13(17), e034438.
  29. Chen YC, Dolladille C, Rao A, Palaskas NL, Deswal A, Lehmann L, Cautela J, Courand PY, Hayek S, Zhu H, Cheng RK, Alexandre J, Baldassarre LA, Roubille F, Laufer-Perl M, Asnani A, Ederhy S, Tamura Y, Francis S, Gaughan EM, Johnson DB, Flint DL, Rainer PP, Bailly G, Ewer SM, Aras MA, Arangalage D, Cariou E, Florido R, Peretto G, Itzhaki Ben Zadok O, Akhter N, Narezkina A, Levenson JE, Liu Y, Crusz SM, Issa N, Piriou N, Leong D, Sandhu S, Turker I, Moliner P, Obeid M, Heinzerling L, Chang WT, Stewart A, Venkatesh V, Du Z, Yadavalli A, Kim D, Chandra A, Zhang KW, Power JR, Moslehi J, Salem JE, Zaha VG, International ICI Myocarditis Registry (2025). Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction. JACC CardioOncol, 7(3), 234-248.
  30. Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, Cautela J, Courand PY, Hayek SS, Zhu H, Zaha VG, Cheng RK, Alexandre J, Roubille F, Baldassarre LA, Chen YC, Baik AH, Laufer-Perl M, Tamura Y, Asnani A, Francis S, Gaughan EM, Rainer PP, Bailly G, Flint D, Arangalage D, Cariou E, Florido R, Narezkina A, Liu Y, Sandhu S, Leong D, Issa N, Piriou N, Heinzerling L, Peretto G, Crusz SM, Akhter N, Levenson JE, Turker I, Eslami A, Fenioux C, Moliner P, Obeid M, Chan WT, Ewer SM, Kassaian SE, Johnson DB, Nohria A, Ben Zadok OI, Moslehi JJ, Salem JE, International ICI-Myocarditis Registr (2026). Immune checkpoint inhibitor-associated myocarditis: a novel risk score. European heart journal, 47(9), 1050-1062.
  31. Sideris K, Bunsawat K, Brinker L, Braun E, Iacovelli J, Chen A, Simmons JM, Zhao J, Carter S, Tseliou E, Kyriakopoulos CP, Hanff TC, Florido R, Brann AM, Fang JC, Greene T, Wray DW, Stehlik (2026). The Effect of Vericiguat on Endothelial Function in Patients With Heart Failure With Reduced Ejection Fraction: A Pilot Randomized Study. The American journal of cardiology, 266, 104-111.
  32. Kyriakopoulos CP, Sideris K, Kyriakoulis I, Taleb I, Maneta E, Zhang C, Tseliou E, Carter S, Florido R, Welt FG, Stehlik J, Selzman CH, Fang JC, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2026). Factors associated with native heart survival and intermediate-term outcomes in acute myocardial infarction-related cardiogenic shock. European heart journal open, 6(1), oeag015.

Review

  1. Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS (2017). 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. [Review]. J Am Coll Cardiol, 70, (24), 3042-3067.
  2. Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Gluckman TJ, Hucker WJ, Mehran R, Messé SR, Perino AC, Rodriguez F, Sarode R, Siegal DM, Wiggins BS (2020). 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. [Review]. J Am Coll Cardiol, 76, (5), 594-622.
  3. Florido R, Smith KL, Cuomo KK, Russell SD (2017). Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies. [Review]. J Am Heart Assoc, 6, (9).
  4. Hu JR, Florido R, Lipson EJ, Naidoo J, Ardehali R, Tocchetti CG, Lyon AR, Padera RF, Johnson DB, Moslehi J (2019). Cardiovascular toxicities associated with immune checkpoint inhibitors. [Review]. Cardiovasc Res, 115, (5), 854-868.
  5. Florido R, Elander A, Blumenthal RS, Martin SS (2015). Statins and Diabetes: Can Risks Outweigh Benefits? [Review]. Curr Cardiovasc Risk Rep, 9, 14.
  6. Bernis K, Florido R, Ndumele CE (2017). The effects of bariatric surgery on the cardiovascular system. [Review]. Curr Cardiovasc Risk Rep, 11, 21.

Book Chapter

  1. Florido R, Tchkonia T, Kirkland JL (2011). Aging and Adipose Tissue. In Masoro EJ, Austad SN (Eds.), Handbook of The Biology of Aging (7th Edition, pp. 119-39). Elsevier.

Case Report

  1. Arvanitis M, Tuday E, Florido R, Hsu S, Choi CW, Sharma K, Schulman SP (2019). Systemic Capillary Leak Syndrome Presenting With Fulminant Recurrent Cardiogenic Shock. Circ Heart Fail, 12(8), e006097.
  2. Vaishnav J, Hsu S, Sharma K, Florido R, Lewsey S, Schulman SP, Chacko M, Kilic A, Choi CW, Gilotra NA (2020). Crossing the Bridge to Heart Transplantation: Biventricular Impella to Support an Unstable LVAD Patient. JACC Case Rep, 2(2), 173-177.
  3. Lázár-Molnár E, Truax CM, Eiting MM, Jain D, Hurst D, Zukauckas K, Pearce A, Bergam S, Gardner S, Clayton F, Florido R, Stehlik J, Shah K (2025). First use of imlifidase desensitization in a highly sensitized heart and liver transplant candidate: A case report. Human immunology, 86(5), 111584.

Editorial

  1. Abovich A, Florido R (2023). Aortic Inflammation: A Predictor of Cardiovascular Disease Risk in Lymphoma Patients? JACC Adv, 2(2), 100283.

Letter

  1. Florido R, Selvin E (2019). Response by Florido and Selvin to Commentary regarding article: "Cancer Survivorship and Subclinical Myocardial Damage: The Atherosclerosis Risk in Communities (ARIC) Study". [Letter to the editor]. Am J Epidemiol.

Other

  1. Florido R, Michos ED (2015). Sitting Disease: Moving Your Way to a Healthier Heart. US News & World Report
  2. Florido R, Ndumele CE (2016). How Obesity Can Affect Your Heart. US News & World Report

Video/Film/CD/Web/Podcast

  1. Florido R, Blumenthal RS, Martin SS (2015). Insights into Statin-Associated Diabetes: How Important is the Risk and How Should You Counsel Your Patient? [Web], American College of Cardiology. Available: http://www.acc.org/latest- incardiology/articles/2015/01/06/08/57/insights-into-statin-associated-diabetes.
  2. Florido R (2018). Breast Cancer Treatment and Your Heart [Web]. Available: https://www.cardiosmart.org/Heart-Conditions/Breast-Cancer-Treatment-and-Your-Heart.
  3. Feldman D, Cuomo K, Blumenthal RS, Florido R (2020). A Closer Look at How to Manage Heart Failure. Evidence-based dietary and medication changes can help promote recovery and a higher quality of life [Web], CardioSmart: American College of Cardiology. Available: https://www.cardiosmart.org/News-and-Events/2020/01/A-Closer-Look-at-How-to-Manage-Heart- Failure.
  4. Fox N, Blumenthal RS, Cainzos Achirica M, Florido R (2020). Physical Activity and Heart Failure in High-Risk Subgroups [Web], American College of Cardiology. Available: https://www.acc.org/latest-in-cardiology/articles/2020/05/15/07/48/physical- activity-and-heart-failure-in-high-risk-subgroups.
  5. Duvall C, Jha K, Blumenthal RS, Florido R (2021). The Myriad Cardiovascular Effects of Obesity [Web], American College of Cardiology. Available: https://www.acc.org/latest-in- cardiology/articles/2021/07/15/19/32/the-myriad-cardiovascular-effects-of-obesity.

News & Podcasts

Huntsman Cancer Institute News